Novartis (ADR)
Develops innovative medicines across four therapeutic areas and multiple advanced technology platforms.
$153.81
After-hours close0.00 (0.00%)
At close$153.81(−0.54%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 7.16%Insiders —
Shares outstanding 1.90B · Float 1.83B · 96.3% free float
Institutions13F, as of Jun 30, 2026
1,665 holders · 136.09M shares · 137 new positions · 670 increased · 577 reduced · 112 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Fisher Asset Management, LLC | 15.52M | 0.82% | +1.64M | Aug 4, 2026 |
| Morgan Stanley | 8.73M | 0.46% | +199.8K | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 8.12M | 0.43% | +7.5K | Aug 11, 2026 |
| Primecap Management Co/CA/ | 6.59M | 0.35% | −975.2K | Aug 14, 2026 |
| Loomis Sayles & Co L P | 5.24M | 0.28% | −186.8K | Aug 14, 2026 |
| Bank of America Corp /DE/ | 4.91M | 0.26% | −52.9K | Aug 14, 2026 |
| Franklin Resources Inc | 3.25M | 0.17% | −158.7K | Aug 13, 2026 |
| BlackRock, Inc. | 3.05M | 0.16% | +98.2K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6.40% | 139.60M | 13G | Jul 17, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.